The impact of the COVID-19 pandemic on Fabry Disease Patients: an examination of Mood Status, Therapy Adherence, and COVID-19 infection

BACKGROUND: Fabry disease (FD) is a rare metabolic disorder, in which a lifelong enzyme replacement therapy (ERT) constitutes the cornerstone of disease-specific therapy. In this study, we examined the effects of the COVID-19 pandemic and lockdown measures on the management of FD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaca, Cebrail, Dincer, Mevlut Tamer, Ozcan, Seyda Gul, Sarac, Betul, Ahmadzada, Saffa, Alagoz, Selma, Bakir, Alev, Kiykim, Ertugrul, Trabulus, Sinan, Seyahi, Nurhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442964/
https://www.ncbi.nlm.nih.gov/pubmed/36064417
http://dx.doi.org/10.1186/s13023-022-02491-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442964/
https://www.ncbi.nlm.nih.gov/pubmed/36064417
http://dx.doi.org/10.1186/s13023-022-02491-7

Ejemplares similares